Genetic analysis can improve depression therapy

12.01.2018 15:00

Photo: www.slideshare.net
Photo: www.slideshare.net

The failure of SSRI antidepressants can be a result of genetic variations in patients. Variations within the gene that encodes the CYP2C19 enzyme results in extreme differences in the levels of escitalopram achieved in patients, according to a new study. Prescribing the dose of escitalopram based on a patient's specific genetic constitution would greatly improve therapeutic outcomes.

More on www.sciencedaily.com ›

Image with code
Comments (0):
advertising
Contact us